DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more
▼ + stars: | 2024-12-17 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Pfizer — Shares traded around 4% higher on the heels of the biopharmaceutical company's 2025 outlook arriving in line with Wall Street expectations . Nvidia , Broadcom — Shares of Nvidia and Broadcom fell more than 1% and nearly 5%, respectively, following the chip stocks' move in opposite directions in prior sessions. On Monday, Nvidia fell into correction territory . Affirm Holdings — Shares fell more than 3% after the buy now, pay later company announced a private offering of $750 million of convertible senior notes . Amentum reported a pro forma loss of 21 cents per share in its fiscal fourth quarter, compared to earnings of 17 cents per share in the year-ago period.

Persons: NASA's, Goldman Sachs, Tesla, Donald Trump's, Amentum, —, Alex Harring, Lisa Kailai Han, Pia Singh, Michelle Fox Organizations: Teva Pharmaceuticals, Sanofi —, Sanofi, duvakitug, Pfizer —, Pfizer, Computing, NASA's Goddard Space Flight Center, Technologies, Nvidia, Broadcom —, Broadcom, Manchester United, UBS, Epam Systems, Cognizant, Solutions, Barclays, Holdings Locations: New Jersey

☆ Jim Cramer wants to buy more of our newest portfolio stock and names his price
▼ + stars: | 2024-12-10 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Jim Cramer noted that the S & P Short Range Oscillator , his trusted momentum indicator, has moved further away from overbought territory. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m.

Persons: Jim Cramer, Eli Lilly, Gilead, Lilly, Jim, Myers, Stocks, Jim Cramer's Organizations: CNBC, Nasdaq, Dow Jones, Bank of America, Tuesday, Merck, Myers Squibb, Bristol, Oracle, General Motors, Toll Brothers, Chevron Locations: outperformance, biopharmaceutical, Lilly, Bristol, MongoDB

☆ Wednesday, December 4, 2024: Cramer wants to use 'every opportunity' to buy more of this pharma stock
▼ + stars: | 2024-12-04 | by ( ) www.cnbc.com time to read: 1 min

Wednesday, December 4, 2024: Cramer wants to use 'every opportunity' to buy more of this pharma stockJim and Jeff discuss earnings for this enterprise software company. They also talk about the latest moves for this biopharmaceutical stock. Finally, they break down the moves of this budget retailer.

Persons: Cramer, Jeff

☆ Goldman Sachs just refreshed its conviction lists of global stocks, giving 3 over 40% upside
▼ + stars: | 2024-12-03 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +4 min

Goldman Sachs has refreshed its lists of top global stock picks for December by adding some and removing others. These stocks are featured in the investment bank's "Conviction List - Directors' Cut," a "curated and active" list of its buy-rated stocks. There have also plenty of additions to the Directors' Cut, including the following three stocks which Goldman gives over 40% upside potential over the next 12 months. KHI's share price has underperformed these two peers by 80% to 100% year-to-date, analyst Yuichiro Isayama noted. PetroChina Goldman is also bullish on Chinese oil and gas giant PetroChina .

Persons: Goldman Sachs, Goldman, Novonesis, Georgina Fraser, Yuichiro Isayama, PetroChina Goldman, Nikhil Bhandari, Bhandari, — CNBC's Michael Bloom Organizations: Companies, Lenovo, Air Liquide, Nasdaq, Kawasaki Heavy Industries, Japan's Kawasaki Heavy Industries, Mitsubishi Heavy Industries, IHI Corporation, Tokyo Stock Exchange, Hong Kong, PetroChina, Shanghai Stock Exchanges, Pan, Matthews China Active Locations: New Zealand, Asia, Europe, Danish, Nasdaq Copenhagen, U.S, Hong Kong, Pan Asia

☆ Wells Fargo sees this biotech stock rallying 75% in its bull case
▼ + stars: | 2024-12-02 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

The success of one of Kymera Therapeutics' experimental treatments could mean more upside ahead for the stock, Wells Fargo found. Analyst Derek Archila upgraded shares to overweight from equal weight and upped his price target by $19 to $57, which implies more than 21% upside from Friday's close. KYMR YTD mountain KYMR, year-to-date The analyst pointed to Kymera's oral treatment for multiple immuno-inflammatory diseases. He anticipates the data will likely demonstrate a "clean" safety profile, and his bull case scenario forecasts shares could trade higher by 75%. Kymera also has a consensus price target of $57.88, which reflects more than 20% upside from current levels.

Persons: Wells, Derek Archila, Archila, Kymera Organizations: Therapeutics, KT Locations: Wells Fargo

☆ Ditch all the negativity: Here's what can go right to lift each of our 34 stocks
▼ + stars: | 2024-11-29 | by ( Paulina Likos | ) www.cnbc.com time to read: +20 min

To counter that, Jim Cramer has said investors should not lose sight of what can go right for their stocks. Smooth chip updates: AMD needs to successfully carry out its annual release cycle for AI chips. That needs to be sustained to justify Meta's heavy spending on AI chips. Nevertheless, correcting this dynamic should translate into faster revenue growth rates. Palo Alto Networks Bigger deals: Cybersecurity is a secular growth market: As the number of bad actors grows, companies can't afford to not invest in defense.

Persons: Jim Cramer, Abbott, Donald Trump, Trump, Joe Biden, Eaton, Eli Lilly, Eli Lilly's GLP, Lilly, Hurricanes Helene, Milton, Elliott Management's, Elliott, Jim, Linde, Morgan Stanley Lower, Morgan, Biden, –, Jensen Huang, Palo, Stanley Black, Brian Niccol's, Wells, Jim Cramer's, Timothy A, Clary Organizations: Abbott, Devices, Microsoft, AMD, Nvidia, Justice Department, Services, Trump, Apple, Apple Intelligence, Federal, Bristol Myers Squibb, Bristol Myers, Broadcom, Constellation Brands, Modelo, Costco, U.S, Netflix, Coterra Energy, LNG, DuPont, GE Healthcare, GE, Hurricanes, Honeywell Business, Honeywell, Linde, Meta, Facebook, Federal Reserve, GOP, Nvidia's, Industry, Palo Alto, Decker, Starbucks, Walt Disney Parks, TJX, Jim Cramer's Charitable Trust, CNBC, Traders, New York Stock Exchange, Getty Locations: U.S, BlackRock, Corona, China, Dover, –, New York City

☆ Monday, November 25, 2024: Cramer sets a bullish target for this pharmaceutical stock
▼ + stars: | 2024-11-25 | by ( ) www.cnbc.com time to read: 1 min

Monday, November 25, 2024: Cramer sets a bullish target for this pharmaceutical stockJim and Jeff discuss why they're buying this biopharmaceutical stock. They also talk about adding to this pharmaceutical stock. Finally, they break down what to expect from this retail stock's earnings.

Persons: Cramer, Jeff

☆ Bank of America says Trump's win will unlock small-cap M&A and these stocks may be takeover candidates
▼ + stars: | 2024-11-15 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

President-elect Donald Trump's White House victory could boost merger and acquisition activity, and Bank of America thinks a group of small-cap stocks may benefit as target candidates. Financial services company Bread Financial Holdings turned up, having a float of 98% of shares outstanding and three-year sales growth of 28%. The biopharmaceutical company has a float of 99% and three-year sales growth of 105%. Commercial Metals Company also showd up on BofA's screen as a potential target. Commercial Metal's three-year sales growth was 18%.

Persons: Donald Trump's, Russell, that's, Lina Khan, Jill Carey, Irving, steelmaker Organizations: Bank of America, Dow Jones Industrial, Republican, House, Senate, Trump, FTC, GOP, Financial, Bread Financial Holdings, Halozyme Therapeutics, Commercial Metals Company Locations: Columbus , Ohio, Diego, Texas

☆ Caligan picks up a stake in Verona Pharma, seeing an opportunity to generate more value
▼ + stars: | 2024-11-09 | by ( Kenneth Squire | ) www.cnbc.com time to read: +7 min

It invests in a concentrated portfolio of small and midcap life sciences companies, using activism as a tool to unlock value. A successful drug like Ohtuvayre would not just increase the life expectancies of patients with COPD, but it would lower costs for both health-care providers and COPD patients. Currently, there are over 8.6 million U.S. COPD patients with over 4 million remaining symptomatic despite treatment from the current commercial therapies. In early pooling analysis, Ohtuvayre showed a 41% reduction in exacerbations in COPD patients, almost double brensocatib. When Caligan announced its Verona position last month, the stock was trading at $33.40 per share or a $2.5 billion enterprise value.

Persons: Caligan, David Johnson, Ohtuvayre, Verona's, Verona, MorphoSys, bode, Ken Squire Organizations: Verona Pharma, Caligan Partners, Carlyle Group, FDA, MorphoSys AG, Novartis, pharma, 13D Locations: Verona, London, MorphoSys, Caligan's

☆ Stocks making the biggest moves premarket: Lyft, SolarEdge, Qualcomm, Moderna and more
▼ + stars: | 2024-11-07 | by ( Brian Evans | ) www.cnbc.com time to read: +5 min

Lyft expects bookings in the current quarter of $4.28 billion to $4.35 billion, while analysts polled by FactSet expected $4.23 billion. SolarEdge — The solar panel inverter stock slipped more than 16% after a third-quarter revenue miss. SolarEdge reported revenue of $261 million, while analysts surveyed by LSEG were looking for $269 million. Third-quarter revenue surpassed Wall Street estimates, and the company expects fourth-quarter revenue of $256 million to $262 million, compared with an estimate of $260 million. Moderna — Shares rallied 7% after Moderna's third-quarter earnings and revenue topped expectations.

Persons: FactSet, SolarEdge, —, Zillow, Gilead, LSEG, Armour, Hershey, Samantha Subin, Hakyung Kim, Sarah Min Organizations: Arm, Wall, LSEG, FactSet, —, Qualcomm, Gilead Sciences, Hershey Locations: Gilead

☆ Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S., posted another quarter of lighter-than-expected sales. Revenue from the shot, Gardasil, fell 11% compared to the year-earlier period, mainly due to lower demand in China. The company booked $16.66 billion in revenue for the third quarter, up 4% from the same period a year ago. The loss of exclusive rights to the medicine will likely cause sales to fall, forcing the company to draw revenue from elsewhere.

Persons: Keytruda, Curon, Merck Organizations: Merck, LSEG Locations: Rahway , New Jersey, U.S, China

☆ AstraZeneca says its China operations president under investigation
▼ + stars: | 2024-10-30 | by ( ) www.cnbc.com time to read: +1 min

The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. AstraZeneca 's China president is under investigation and is cooperating with Chinese authorities, the company said on Wednesday, sending shares down as much as 5.3%. When asked about Wang's whereabouts, a company spokesperson only reiterated that the executive was under investigation. In a statement, the drugmaker said its Chinese operations were "under the leadership of the current general manager of AstraZeneca China," without providing further details. AstraZeneca shares were down 5.2% at 1352 GMT.

Persons: Leon Wang Organizations: AstraZeneca Locations: Shanghai, China, drugmakers, United States, AstraZeneca China

☆ Jim Cramer's latest thinking on our industrial stocks after their post-earnings slumps
▼ + stars: | 2024-10-25 | by ( Paulina Likos | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. "So, maybe we hold on, but I've got to tell you, if it gets back to where it was, I've had enough of Honeywell," Jim said. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jim, Dover's, They've, I've, Stocks, Jim Cramer's, DOV Organizations: CNBC, Big Tech, Apple, Mobile, Verizon, Amazon, Honeywell, Digital, Colgate, Palmolive, Newell Brands Locations: Dover

☆ In the competitive world of pharma, companies need to focus on worker well-being to retain top talent, says Ferring's HR exec
▼ + stars: | 2024-10-15 | by ( Julia Hood | ) www.businessinsider.com time to read: +7 min

She said that Ferring has grown more intentional about focusing on worker well-being, which is particularly important for the highly competitive field of healthcare. What are the benefits for companies focused on worker well-being? We've defined well-being in a holistic way, so it's not just about physical well-being; it's also about mental well-being and financial well-being. What advice do you have for other companies that are just getting started thinking about DEI and worker well-being initiatives? What policies demonstrate your focus on worker well-being?

Persons: —, Johnson, JP Morgan, Ferring, We've, it's, I've, we've, you've Organizations: Ferring Pharmaceuticals, Service, gastroenterology, Johnson, American Express, Pharma, pharma Locations: Swiss, Switzerland

☆ Stocks making the biggest moves midday: Rivian, Abercrombie & Fitch, CVS, Spirit Airlines and more
▼ + stars: | 2024-10-04 | by ( Pia Singh | In | ) www.cnbc.com time to read: +2 min

Abercrombie & Fitch - Shares of the teen apparel retailer jumped nearly 8% after JPMorgan added it to its positive catalyst watch list. JetBlue shares jumped more than 15% on the news. Summit Therapeutics – The biopharmaceutical company added 2%. Other international shipping stocks saw losses as well, including Danish shipping giant Maersk at 5% . CVS Health — The company's shares added 3.3%.

Persons: Abercrombie &, Matthew Boss, Hollister, Tencent, — CNBC's Sean Conlon, Hakyung Kim, Christina Cheddar, Berk, Lisa Kailai Han Organizations: Abercrombie, Abercrombie & Fitch, JPMorgan, Spirit Airlines, JetBlue Airways —, Wall Street, JetBlue, Vistra, Nvidia, Therapeutics, Drug Administration, Ubisoft Entertainment, Bloomberg News, Ubisoft, SilverCrest Metals, Mining, Zim Integrated Shipping Services —, U.S, dockworkers, United States Maritime Alliance, Maersk, CVS Health, CNBC, CVS

☆ Stocks making the biggest moves premarket: Spirit Airlines, Summit Therapeutics, Rivian and more
▼ + stars: | 2024-10-04 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Spirit Airlines , JetBlue – Spirit plunged more than 38% following a report from The Wall Street Journal that the discount airliner is considering filing for bankruptcy. Shares of peer airline firm JetBlue, which was previously in talks to merge with Spirit, advanced nearly 6%. Zim Integrated Shipping Services – The international shipping company's stock fell more than 9% after U.S. dockworkers and the United States Maritime Alliance agreed to a tentative deal to end the strike on the East Coast and Gulf Coast ports. CVS Health – The company's shares added 1.5% as it is considering breaking itself up and undergoing a strategic review of its business. Chubb – The insurance company slipped more than 1% after Bank of America downgraded shares to underperform from neutral.

Persons: Hapag, Lloyd, Rivian, Chubb, SilverCrest, —, Jesse Pound, Brian Evans, Hakyung Kim, Pia Singh, Michelle Fox Theobald Organizations: Spirit Airlines, JetBlue, Wall Street Journal, Food and Drug Administration, Zim Integrated Shipping Services, U.S, dockworkers, United States Maritime Alliance, CVS Health, CVS, Bank of America, SilverCrest Metals, Coeur Locations: East Coast, Gulf Coast

☆ Stocks making the biggest moves premarket: Bristol-Myers Squibb, Costco, Super Micro Computer and more
▼ + stars: | 2024-09-27 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Costco Wholesale — The membership-only retailer saw shares dip about 1% after the company missed expectations for fiscal fourth-quarter revenue. Super Micro Computer — Shares of the artificial intelligence beneficiary slipped 2%, adding to their 12% loss in the previous session. The Wall Street Journal reported that the U.S. Justice Department had opened a probe on the company. Dollar General — Shares fell 2% after Citi downgraded Dollar General to sell from neutral, saying Walmart 's increasing dominance in retail, especially on pricing, has the dollar store "on the wrong side." HP Inc. — The tech hardware stock fell about 2% after a downgrade to neutral from buy at Bank of America.

Persons: Myers Squibb, Costco, Hindenburg, Morgan Stanley, —, KeyBanc, — CNBC's Hakyung Kim, Lisa Kailai Han, Yun Li, Sarah Min, Jesse Pound, Samantha Subin, Michelle Fox Organizations: Myers, U.S . Food, Drug Administration, Novo Nordisk —, JPMorgan, Costco Wholesale, Revenue, Street Journal, U.S . Justice Department, U.S . Securities, Exchange Commission, Wynn Resorts, Citi, Walmart, HP Inc, Bank of America, HP Locations: Bristol, U.S, Novo Nordisk — U.S, Danish

☆ These China stocks are favored by analysts no matter how the central bank stimulus pans out
▼ + stars: | 2024-09-26 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +3 min

Stocks in China rose in response, with the CSI 300 Index climbing 4.3% Tuesday, its best day since July 2020. But whether or not the latest policy steps succeed, CNBC Pro screened for China stocks that analysts praise regardless of the pace of economic growth at home. About three quarters of analysts covering PDD rate it a buy, and the stock could climb roughly 43% based on analysts' consensus price target. On Tuesday, after the announcement of the latest policies to revive the flagging China economy, PDD shares in the U.S. jumped more than 11%. Other names on the list of favored China stocks included online learning and tutoring provider TAL Education Group and digital shipping platform Full Truck Alliance .

Persons: Hong, Morgan Stanley, Terence Flynn, Flynn, CoreValues, Ben Harburg, CNBC's, Harburg, Biden Organizations: People's Bank of China, CSI, CNBC Pro, China ETF, Therapeutics, YE25, U.S, TAL Education Group, Alliance Locations: China, Ph3, U.S

☆ Goldman sees this biotech fighting rare diseases rallying 35%
▼ + stars: | 2024-09-24 | by ( Alex Harring | ) www.cnbc.com time to read: +1 min

Analyst Corinne Johnson initiated coverage of the biopharmaceutical stock focused on unique diseases at a buy rating. "Our positive view of the company is based on what we view as multi-blockbuster, first-to-market commercial opportunities ... coupled with the scalable nature of the company's antibody oligonucleotide conjugate platform," Johnson wrote to clients. The first is del-brax, a drug designed to fight facioscapulohumeral muscular dystrophy, or FSHD — which has estimated peak sales of $2.7 billion. The other is del-desiran, a therapy to treat myotonic dystrophy type 1, or DM1 — with a predicted peak sale figure of $4 billion. Shares have soared more than 380% in 2024, reversing course after dropping more than 59% last year.

Persons: Goldman Sachs, Corinne Johnson, Johnson, what's Organizations: Avidity Biosciences, LSEG Locations: Monday's

☆ Here are 3 stocks to buy after the Fed's 'crisis level cut,' according to one strategist
▼ + stars: | 2024-09-23 | by ( Amala Balakrishner | In Amala-Balakrishner | ) www.cnbc.com time to read: +4 min

The move they made is a big cut," SlateStone Wealth's Kenny Polcari told CNBC's " Street Signs Asia " on Sept. 19. Calling it a "crisis level cut," he added that "people [are] scratching their heads, going, what's it really mean?" Federal Reserve Chair Jerome Powell stressed that the big rate cut does not signal that the risk of a recession is elevated. According to FactSet data, of the 20 analysts covering the stock, 18 give it a buy or overweight rating, while two have a hold rating. Biotech play Another stock Polcari is bullish on is biopharmaceutical player Amgen , given its pipeline of new products .

Persons: Kenny Polcari, CNBC's, Jerome Powell, Polcari, Amgen, — CNBC's Sean Conlon Organizations: U.S, Biotech, U.S . Food, Drug Administration, Euronext, Nasdaq, Nvidia Locations: Federal, U.S, Amgen, Euronext Amsterdam, Dutch, ASML

☆ Stocks making the biggest moves midday: Tesla, Mobileye Global, Darden Restaurants and more
▼ + stars: | 2024-09-19 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Check out the companies making headlines in midday trading: Tech stocks — Key tech names rallied a day after the Federal Reserve's supersized rate cut decision. Coursera — The online education platform jumped more than 8% on the back of Bank of America's initiation at a buy rating. Uber shares rose 3%. NextEra Energy Partners — The stock rose more than 3% on the heels of Jefferies initiating coverage with a buy rating. Crypto stocks — Stocks tied to bitcoin's price climbed as the cryptocurrency moved more than 4% higher following the Fed's rate cut on Wednesday.

Persons: Tesla, Meta, Coursera, Uber, DoorDash, Jefferies, Stocks, MicroStrategy, Alibaba, Alex Harring, Samantha Subin, Lisa Kailai Han, Pia Singh, Michelle Fox Organizations: Tech, Federal, Nvidia, Therapeutics, Intel, Bank of, Darden, DoorDash, NextEra Energy Partners, JPMorgan Locations: Mobileye, Olive

☆ Stocks making the biggest moves midday: Nuvalent, Alcoa, Sprouts Farmers Market, Apple and more
▼ + stars: | 2024-09-16 | by ( Sean Conlon | ) www.cnbc.com time to read: +3 min

Upstart Holdings – Shares of the personal finance firm fell 5% after the announcement of a new debt offering. Sprouts Farmers Market – Shares of the supermarket chain rose nearly 5% following an upgrade to outperform from in line at Evercore ISI. The investment firm wrote that Sprouts, which specializes in organic products, could be a beneficiary of a trend towards healthier eating. Apple – Shares slumped 3% following reports of sluggish demand for some of the company's latest iPhone models. Yelp – Shares dropped 4% after Bank of America initiated coverage of Yelp with an underperform rating.

Persons: Nuvalent, Bausch, Goldman Sachs, Morgan Stanley, Donald Trump, Ming, Chi Kuo, —, Alex Harring, Samantha Subin, Yun Li, Lisa Kailai Han, Pia Singh, Jesse Pound Organizations: Financial Times, FT, Alcoa, Intel –, Bloomberg, Intel, Pentagon, Micron Technology, Evercore ISI, Trump Media & Technology, Apple –, TF Securities, Apple, JPMorgan, Bank of America Locations: California

☆ Stocks making the biggest moves premarket: Boeing, Oracle, Moderna and more
▼ + stars: | 2024-09-13 | by ( Samantha Subin | ) www.cnbc.com time to read: +1 min

Boeing — The stock sank 4% after Boeing factory workers went on strike early Friday after rejecting a new labor contract. Oracle — Shares of the database software company rallied more than 6%. Oracle lifted its fiscal 2026 revenue forecast and shared strong guidance for the 2029 fiscal year. RH — Shares of the home furnishings retailer surged 21% after a stronger-than-expected second quarter. Adobe — Shares sank more than 8% after the company issued softer-than-expected guidance for the current quarter.

Persons: Max, Kevin Clark, — CNBC's Michelle Fox, Lisa Han, Sarah Min, Jesse Pound Organizations: Boeing, Oracle —, Oracle, Moderna —, JPMorgan, —, Adobe —, Adobe, Aptiv, U.S . Securities, Exchange Commission, AstraZeneca —, Deutsche Bank

☆ A promising cancer treatment is poised for explosive growth, says Redburn Atlantic. These stocks are on its buy list
▼ + stars: | 2024-09-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +5 min

The latest weapon in the battle against cancer is showing promising results — and it's a growing opportunity for investors, according to Redburn Atlantic. To treat cancer, targeted radiopharmaceutical therapy directly goes after tumors with radiation by binding a radioactive particle to a targeting molecule. Delving into diagnostics There are also opportunities in the radiopharma diagnostics space, according to Redburn Atlantic. It has a "strong pipeline of radionuclides for both diagnosis and therapy," he said. "Lantheus benefits from its focus on this rapidly expanding market, with 78% of revenues from radiopharmaceuticals and related products," Ridley-Day added.

Persons: Ed Ridley, Eli Lilly, Myers, Ridley, Astra's, Lantheus Organizations: Big pharma, Novartis, Mariana Oncology, Biopharma, Myers Squibb, RayzeBio, AstraZeneca, Fusion Pharmaceuticals, GE Healthcare Technologies, Lantheus Holdings, GE Healthcare, GE Locations: Bristol, radiopharmaceuticals

☆ Stocks making the biggest moves midday: Kroger, Petco, Moderna, Roku and more
▼ + stars: | 2024-09-12 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

That builds on Wednesday's post-earnings rally of nearly 33%, which marked the stock's best day on record. Moderna — The stock plummeted nearly 16% after the drugmaker said it will cut $1.1 billion in expenses by 2027. Interpublic Group of Companies — The advertising stock was trading 2% lower following a downgrade from UBS to sell from neutral. U.S. Bancorp — The bank stock slipped nearly 2% despite announcing a dividend hike and a $5 billion share buyback plan. Oracle – Shares of the software company rose nearly 2% after Bernstein named it a top investment idea .

Persons: Kroger –, Kroger, Moderna, Adam Berlin, Bernstein, Yun Li, Michelle Fox, Sean Conlon, Samantha Subin, Lisa Kailai Han, Sarah Min Organizations: Kroger, Moderna, Gilead Sciences, Alaska Air Group, Interpublic, Companies, UBS, Amazon, Pfizer, Bancorp, Diageo, Bank of America, Wolfe Research, Oracle – Locations: Gilead, Alaska, U.S

Search resuls for: "biopharmaceutical"

25 mentions found